PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8+T cells and promoting fatty acid metabolism
Background The phosphatidylinositol 3-kinase (PI3K) is frequently hyperactivated in cancer and plays important roles in both malignant and immune cells. The effect of PI3Kα inhibitors on the tumor microenvironment (TME) remains largely unknown. Here, we investigated the modulation of the TME by a cl...
Main Authors: | Xi Zhang, Yi Wang, Jian Ding, Lan Xu, Pu Sun, Rong-Jing Wang, Qing-Yang Ma, Hui-Ping Liao, Hai-Long Wang, Lan-Dian Hu, Xiangyin Kong, Ling-Hua Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-08-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/9/8/e003093.full |
Similar Items
-
Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells
by: Yu-xiang Wang, et al.
Published: (2021-01-01) -
New Thio-Compounds and Monoterpenes With Anti-inflammatory Activities From the Fungus Aspergillus sp. CYH26
by: Guojun Pan, et al.
Published: (2021-03-01) -
Design and Control Configuration Studies of a Complete IPA-H2O-CyH Heterogeneous Azeotropic Distillation System
by: Wu, Chun-Ming, et al.
Published: (2009) -
Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor.
by: Yuki Masuda, et al.
Published: (2017-01-01) -
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
by: Jennifer L Leddon, et al.
Published: (2014-01-01)